肝细胞癌(HCC)的预防:德克萨斯州肝细胞癌协作中心(TeCH)多方利益相关者会议白皮书
德克萨斯州肝细胞癌年龄调整发病率全美最高;TeCH与贝克研究所于2022年9月17日联合举办多方利益相关者会议,旨在识别HCC预防策略并评估其实施准备度;会议呼吁全州开展四项工作:病毒性肝炎消除计划、非酒精性脂肪性肝炎与肥胖意识提升计划、整合酒精相关性肝病与酒精使用障碍治疗的健康照护模式研究、以及识别并衔接晚期纤维化与肝硬化患者至临床照护的示范项目。
要点
- 德克萨斯州肝细胞癌年龄调整发病率全美最高。
- 会议旨在识别HCC预防策略并评估其准备度。
- 呼吁全州实施病毒性肝炎消除等四项计划。
核心结论
- 呼吁全州开展病毒性肝炎消除计划。
- 呼吁全州开展提升非酒精性脂肪性肝炎与肥胖意识的计划。
- 呼吁开展研究以开发整合酒精相关性肝病与酒精使用障碍治疗的健康照护模式。
- 呼吁开展示范项目评估识别晚期纤维化与肝硬化患者并衔接至临床照护的有效性。
研究设计与样本
- 德克萨斯州癌症预防与研究所资助的TeCH与贝克研究所健康与生物科学中心于2022年9月17日联合主办多方利益相关者会议。
- 会议参加者包括德克萨斯州内外的HCC研究者、政策制定者、支付方、制药行业成员和患者倡导团体成员。
- 本报告总结会议结果。
主要发现
- 会议目标是识别不同HCC预防策略并评估其实施准备度。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. The Cancer Prevention and Research Institute of Texas has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate HCC research, education, and advocacy activities with the overall goal of reducing HCC mortality in Texas through coordination, collaboration, and advocacy. METHODS: On September 17, 2022, TeCH co-sponsored a multi-stakeholder conference on HCC with the Baker Institute Center for Health and Biosciences. This conference was attended by HCC researchers, policy makers, payers, members from pharmaceutical industry and patient advocacy groups in and outside of Texas. This report summarizes the results of the conference. RESULTS: The goal of this meeting was to identify different strategies for preventing HCC and evaluate their readiness for implementation. CONCLUSIONS: We call for a statewide (1) viral hepatitis elimination program; (2) program to increase nonalcoholic steatohepatitis and obesity awareness; (3) research program to develop health care models that integrate alcohol associated liver disease treatment and treatment for alcohol use disorder; and (4) demonstration projects to evaluate the effectiveness of identifying and linking patient with advanced fibrosis and cirrhosis to clinical care.
引用
- El-Serag HB, Ward JW, Asrani SK, et al. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. Clin Gastroenterol Hepatol. 2023. PMID: 37086825. doi:10.1016/j.cgh.2023.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。